Paul Daruwala - 29 Dec 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Operating Officer
Signature
/s/ Paul Daruwala
Issuer symbol
CDTX
Transactions as of
29 Dec 2021
Net transactions value
-$6,416
Form type
4
Filing time
07 Jan 2022, 19:26:07 UTC
Previous filing
04 Oct 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Options Exercise $0 +9,900 +5.4% $0.000000 192,431 29 Dec 2021 Direct F1
transaction CDTX Common Stock Sale $6,416 -5,133 -2.7% $1.25 187,298 05 Jan 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Restricted Stock Unit Options Exercise $0 -5,000 -29% $0.000000 12,500 29 Dec 2021 Common Stock 5,000 Direct F3, F4
transaction CDTX Restricted Stock Unit Options Exercise $0 -4,900 -47% $0.000000 5,600 29 Dec 2021 Common Stock 4,900 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F3 Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4 On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
F5 On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.